Brainstorm Cell Therapeutics Inc. (BCLI) - Yalpi foyda normasi

BCLI (Brainstorm Cell Therapeutics, Inc.) - kompaniyaning tovar belgisi

Brainstorm Cell (BCLI) biznesining rivojlanishi bozor sikllaridan mustaqildir, chunki uning muvaffaqiyati klinik sinovlarga bog'liq. GURU.Markets platformasida yalpi foyda marjasi tendentsiyasi 0.00 ning joriy qiymatini namoyish etib, tasodifiy shovqinlarni filtrlashga yordam beradi. Brainstorm Cell (BCLI) tashqi investitsiyalar va grantlarga tayangan holda, Altsgeymer va ALS kasalliklariga qarshi kurashish uchun hujayraviy platformalar yaratmoqda. Hozirgi vaqtda NuOwn dori vositasi tartibga soluvchi tasdiqlash bosqichidan o'tmoqda.

Brainstorm Cell Therapeutics, Inc. (BCLI): Yalpi marja 04.07.2022dan 02.08.2025gacha

Brainstorm Cell (BCLI) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

BrainStorm Cell Therapeutics Inc. tayyor mahsulotlari

Yalpi foyda marjasi bevosita ishlab chiqarish xarajatlarini qoplagandan keyin qolgan daromad qismini o'lchaydi va asosiy operatsion modelning samaradorligini aks ettiradi. Yalpi foyda marjasi koeffitsientini tahlil qilish hisobot ma'lumotlarining dinamikasi orqali rentabellikning pasayishi va katta yo'qotishlar xavfini tezkor aniqlash imkonini beradi. Brainstorm Cell (BCLI) uchun ushbu ko'rsatkich moliyaviy barqarorlikni tasdiqlaydi va shu bilan birga neyrodegenerativ kasalliklar uchun bir nechta terapiya dasturlarini ishlab chiqish orqali umumiy tartibga soluvchi xavflarni kamaytiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)